LP s obsahem risankizumabu 2026
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
30 / 100
Risk factors
Essential details (financial standing, references, technical requirements) are missing from the notice and procurement...
Lowest price criterion may lead to aggressive pricing and thin margins.
Submission deadline in 8 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- CZK 25.8M estimated value
- Supplies contract
- 1 lot
- Repeated supplies of medicinal products with active substance risankizumab.
Show full summary
Czech open tender for repeated supplies of medicinal products with active substance risankizumab (immunosuppressive agent). Single lot, 36-month duration, award based on lowest price. Submission deadline 2026-07-02, estimated value 25,819,875 CZK. Electronic submission required via eGordion profile, language Czech.
Risks
Essential details (financial standing, references, technical requirements) are missing from the notice and procurement...
Lowest price criterion may lead to aggressive pricing and thin margins.
Submission deadline in 8 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Open procedure
Administrative
- Electronic submission required via Open portal
- Submission language: Czech (CES)
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Name
Fakultní nemocnice Olomouc
Location
Olomouc - Nová Ulice, CZE
Website
Buyer profile
Identifier
00098892
Lots (1)
LOT-0001
LP s obsahem risankizumabu 2026
Repeated deliveries of medicinal products containing risankizumab. Single lot covering all requirements.
CZK 25.8M
Estimated value
Location
Category
Deadline
Award details
Value note
Show original TED data
Original TED description
Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků s obsahem účinné látky risankizumab.
Procurement Details
- Publication date
- 28 May 2026
- Notice type
- Contract notice — standard
- Languages
- Czech
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 370649-2026
- Source notice ID
- 46964ee5-7b3e-4238-876a-2e9a19a1845a
Documents (1)
Similar tenders
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Poland – Immunoglobulins – Dostawy produktów leczniczych, wyrobów medycznych oraz substancji do receptury
Poland – Immunosuppressive agents – Dostawa środków immunosupresyjnych, produktów leczniczych dla układu nerwowego, produktów leczniczych dla organów zmysłów, środków leczniczych dla układu oddechowego, produktów leczniczych dla przewodu pokarmowego i metabolizmu, produktów leczniczych stosowanych przy cukrzycy, insuliny, płynów dożylnych, ogólnoustrojowych preparatów hormonalnych, z wyłączeniem hormonów płciowych oraz różnych...
Czechia – Immunosuppressive agents – LP s obsahem certolizumab pegolu 2026
Czechia – Immunosuppressive agents – LP s obsahem risankizumabu 2026
Czechia – Immunosuppressive agents – Ixekizumab
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
30 / 100
Risk factors
Essential details (financial standing, references, technical requirements) are missing from the notice and procurement...
Lowest price criterion may lead to aggressive pricing and thin margins.
Submission deadline in 8 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications